S69 Glucocorticoids in Brain Remodeling

Program: Symposia
Basic/Translational Session
Monday, April 4, 2016: 11:45 AM-1:15 PM
Room 109 (BCEC)
Chair:
Ashley B. Grossman, MD, University of Oxford, Oxford, United Kingdom

Disclosures:
ABG: Ad Hoc Consultant, Novartis Pharmaceuticals, Ad Hoc Consultant, Ipsen.
11:45 AM
Freddy Jeanneteau, PhD, Physiology, Institut de Genomique Fonctionnelle Inserm U1191 CNRS UMR5203, Montpellier, France
Nothing to Disclose: FJ
12:15 PM
Marian Joƫls, PhD, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, Netherlands
Disclosures:
MJ: Investigator, Corcept.
12:45 PM
Jason J Radley, PhD, Psychological and Brain Sciences, University of Iowa, Iowa City, IA
Nothing to Disclose: JJR
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire